Health Ministry reviews the development of breast cancer treatment protocols under the President of the Republic's Initiative to Support Women's Health.
The Ministry of Health and Population held a press conference to review the progress achieved by the State in developing the care system for breast cancer patients and the inclusion of immunotherapy in the treatment protocols of the President of the Republic's Initiative to Support Women's Health, in cooperation with MSD Egypt.
Dr. Mohamed Hassany, Assistant Minister of Health for Public Health Initiatives, said that the Presidential Initiative is a successful model of partnership between the State and the private sector, as the presidential public health initiatives have, since 2018, provided more than 240 million services to more than 93 million citizens, while the Women's Health Support Initiative alone has provided more than 70 million services benefiting more than 23 million women.
He added that the initiative has contributed to the detection of about 40,000 cases of breast cancer, 80% of them at early stages, which has raised cure rates and reduced the average time between diagnosis and the start of treatment from 180-280 days to only 49 days, and lowered the proportion of late-stage cases from 60% to 19.5%.
Dr. Tamer El-Husseiny, Vice-Chairman of the Egyptian Drug Authority, affirmed the Authority's role in accelerating the registration and evaluation procedures for innovative treatments to ensure they reach patients in line with the highest quality standards.
For his part, Dr. Mohamed El-Akkad, Director of the General Department of Specialised Medical Councils, reviewed efforts to unify treatment protocols and prepare a unified guideline, as well as the establishment of specialised units to support decision-making based on health data.
Dr. Hesham El-Ghazaly, Head of the initiative's Scientific Committee, pointed to the creation of the largest national breast cancer database, and the development of treatment protocols based on scientific evidence and the Egyptian context.
Dr. Hatem Amin, Executive Director of the initiative, explained that the scientific committees are keen to update the protocols periodically to keep pace with the latest global practices while ensuring financial sustainability, affirming that treatment is provided free of charge to all patients.
For her part, Dr. Radwa Emam, Director of the General Department of Awareness and Health Promotion Programmes at the General Authority for Healthcare, affirmed the commitment to expanding the provision of the initiative's services within the facilities of the Universal Health Insurance system, by increasing service delivery points and applying the latest treatment protocols, as well as implementing awareness programmes for early detection and promoting health awareness.
Dr. Hazem Abdel Samie, Managing Director of MSD Egypt, said: "We are proud to cooperate with the Ministry of Health to support an integrated pathway that begins with early detection and extends to improving long-term quality of life, by harnessing scientific innovation and strengthening partnerships to provide fairer opportunities for patients."
At the close of the event, Dr. Mohamed Hassany thanked the initiative's work teams, the Scientific Committee and the medical staff for their continuous efforts in enhancing the quality of healthcare for women.